SCHEMBL26055397

SCHEMBL26055397

O=S(O)CCCn1ncc2ccncc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 7/20 0.39
FGFR1 P11362 1/20 0.38
FGFR4 P22455 1/20 0.38
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
P2RX7 Q99572 1/20 0.34
CYP1A2 P05177 1/20 0.33
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32
GABRA4 P48169 1/20 0.32
GABRE P78334 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22965256 0.80 KMO (0.33) KMOFGFR1FGFR4P2RX7CYP1A2
SCHEMBL29328557 0.78 KMO (0.63) KMOFGFR1FGFR4
SCHEMBL29972506 0.77 KMO (0.41) KMOFGFR1FGFR4HTR2AHTR2C
SCHEMBL29328869 0.77 FGFR1 (0.39) KMOFGFR1FGFR4HTR2AHTR2C
SCHEMBL8803921 0.76 SLC9A1 (0.40) KMOFGFR1FGFR4HTR2AHTR2C
SCHEMBL26067851 0.75 FGFR1 (0.38) KMOFGFR1FGFR4HTR2AHTR2C
SCHEMBL22965255 0.72 KDM4E (0.44) KMO
SCHEMBL29972445 0.71 KMO (0.59) KMOFGFR1FGFR4GABRPGABRD
SCHEMBL13978502 0.70 KMO (0.43) KMOFGFR1FGFR4HTR2AHTR2C
SCHEMBL21501930 0.70 HASPIN (0.49) FGFR1FGFR4HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023161409-A1 METHODS FOR PURIFICATION, DETECTION AND QUANTIFICATION OF RESIDUAL PEI-BASED TRANSFECTION REAGENTS POLYPLUS TRANSFECTION (FR) 2023-08-31 WO disclosed